News

November 10, 2015November 12, 2015

New Metastatic Melanoma Treatment from Caladrius Shows Promise

News

Caladrius Biosciences, Inc., recently presented novel data at the 2015 Annual Meeting of the Society for Immunotherapy of Cancer (SITC), which took place in Baltimore, Maryland, Nov. 4-8, 2015. The clinical and ... Read more

November 5, 2015November 5, 2015

IMLYGIC, an Unresectable Melanoma Treatment, Gets Positive CHMP Opinion

News

Amgen announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), has given a positive recommendation for IMLYGIC (talimogene laherparepvec) as a treatment for adult ... Read more

November 5, 2015November 5, 2015

La Roche-Posay Promotes ‘SOS-Save Our Skin’ Program for 5th Year

News

La Roche-Posay, a global leader in ultraviolet (UV) protection, is continuing its work to increase public awareness of  skin cancer and prevention with its SOS – Save our Skin Campaign, now in ... Read more

October 22, 2015October 22, 2015

For Treatment-Naive Melanoma Patients, Nivolumab May Hold Added Benefit

News

According to a recently released collection of papers (dossier) by the Institute for Quality and Efficiency in Health Care (IQWiG), use of the drug Nivolumab (trade name: Opdivo) may be ... Read more

October 20, 2015October 22, 2015

‘Mole Mapper’ iPhone App to Aid Understanding of Melanomas in Research Study

News

Seattle, Washington-based, nonprofit biomedical research organization Sage Bionetworks, in collaboration with Oregon Health & Science University (OHSU) and National Cancer Institute cancer biologist Dan Webster, PhD, has  announced the launch of ... Read more

October 15, 2015October 22, 2015

Dr. Alberto Pappo Interviewed About Pediatric Melanoma

News

Estimates indicate that each year in the United States, there are about 400 new diagnosis of melanoma among those younger than 19 years of age. According to the St. Jude Children’s ... Read more

October 13, 2015October 13, 2015

Opdivo/ Yervoy Regimen Receives FDA Approval for BRAF V600 Wild-Type Unresectable or Metastatic Melanoma

News

Bristol-Myers Squibb Company announced it has received US Food and Drug Administration (FDA) approval for the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) in the treatment of patients diagnosed with BRAF V600 wild-type unresectable or metastatic melanoma ... Read more

October 1, 2015October 13, 2015

Arteries Are Better Than Veins for Liquid Biopsy, According to Study

News

Researchers from Thomas Jefferson Medical School (TJMS), Philadelphia, have recently released study findings which may hold important implications for a novel test currently approved for use to detect circulating tumor ... Read more

September 24, 2015September 24, 2015

NICE Approves Keytruda for Melanoma

News

Melanoma patients in England who have ceased responding to standard-of-care treatments can soon avail of a new immunotherapy drug that works by “unmasking” cancer cells and reprogramming the body’s immune system ... Read more

September 22, 2015September 25, 2015

Novel Discoveries May Hold Answers For Treatment-Resistant Melanoma

News

UCLA scientists have recently released study findings which may hold important implications in the field of metastatic melanoma research. The study entitled, “Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance“, ... Read more

September 17, 2015September 17, 2015

Immune Irregularities May Increase Melanoma Risk Among Certain Non-Hodgkin’s Lymphoma Survivors

News

A collaborative team of interdisciplinary researchers led by Clara J.K. Lam, MPH, a predoctoral fellow in the Radiation Epidemiology Branch of the National Cancer Institute (NCI) and PhD student in cancer ... Read more

September 15, 2015September 15, 2015

Adding Aspirin to Cancer Immunotherapy Slows Tumor Growth in Mice

News

A multidisciplinary team of researchers from the Francis Crick Institute, with funding from Cancer Research UK, have recently released results that could advance immunotherapy treatment options for certain cancers, such as ... Read more

September 10, 2015September 15, 2015

EMA Accepts Immunocore’s IMCgp100 for Adaptive Pathway Pilot Program In Melanoma

News

Immunocore Limited, one of the world’s leading biotechnology companies with a highly innovative immuno-oncology platform technology called ImmTACs, has just announced its lead product candidate, IMCgp100, has been accepted by the European Medicines ... Read more

September 3, 2015September 3, 2015

Researchers Identify Novel Mutation in Melanoma Cancer Cells

News

In a recent study published in Science Signaling entitled “The E3 ligase APC/CCdh1 promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth“, scientists from the Boston University School ... Read more

September 1, 2015September 14, 2015

SciBase US Reader Study for Nevisense Arrives at Positive Results, Improves Melanoma Diagnoses Accuracy

News

SciBase AB, a Swedish medical technology company headquartered in Stockholm, has recently announced the results of its US Reader Study. According to SciBase, the addition of Nevisense, which uses Electrical Impedance Spectroscopy ... Read more

August 28, 2015August 28, 2015

Not All Dermatology Treatments Are Necessary, According to The American Academy of Dermatology

News

The American Academy of Dermatology has recently updated its recommendations on a wide variety of dermatologic tests and treatments that may not be medically necessary. Costly tests are sometimes done on patients with ... Read more

August 24, 2015August 25, 2015

Radio Host and Research Center Founder Sharon Kleyne Reports on Dangers of Malignant Melanoma, Sun Exposure and Dehydration

News

With summers coming in earlier and lasting longer, and the sun’s UV rays growing all the more harsh in several parts of America, Sharon Kleyne, host of the Sharon Kleyne Hour Power ... Read more

August 21, 2015August 21, 2015

Having Fewer Moles Could Correlate To Worse Melanoma Diagnosis

News

When it comes to predicting risk for skin cancer, many of us, including physicians, believe having more than 50 moles puts one at a much higher risk of developing melanoma. ... Read more

August 19, 2015August 19, 2015

New Therapeutic Approach for Metastatic Melanoma Based on Pin1-FOXM1 Interaction

News

A study recently published in the journal Oncogene revealed a new therapeutic strategy for advanced metastatic melanoma based on the interaction between two particular factors – Pin1 and FOXM1. The ... Read more

August 17, 2015August 17, 2015

Study Shows Increased Melanoma Risk Among Transplant Recipients

News

A research team from Johns Hopkins Bloomberg School of Public Health found transplant recipients are more likely to develop aggressive forms of melanoma. The study entitled “Melanoma Risk and Survival Among ... Read more